Nuvalent, Inc.

Stocks

NUVL

US6707031075

Delayed Nasdaq Other stock markets 04:00:00 2026-07-14 pm EDT			5-day change	1st Jan Change
123.96 ^USD	+0.02%		+0.15%	+23.23%

02:21pm	GlaxoSmithKline LLC completed the acquisition of Nuvalent, Inc. from Deerfield Management Company, L.P. and others.	CI
10:33am	GSK Completes $10.6 Billion Acquisition of Nuvalent	MT

Transcript : GSK plc, Nuvalent, Inc. - M&A Call

Published on 06/10/2026 at 04:52 am EDT - Modified on 06/18/2026 at 04:06 am EDT

S&P Capital IQ

Add MarketScreener to your sources

Presenter Speech
Constantin Fest (Executives)

A warm welcome to this GSK call on our agreement to acquire Nuvalent. My name is Constantin Fest, Investor Relations. I'm delighted to have here today with

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about Nuvalent, Inc.

02:21pm	GlaxoSmithKline LLC completed the acquisition of Nuvalent, Inc. from Deerfield Management Company, L.P. and others.	CI
10:33am	GSK Completes $10.6 Billion Acquisition of Nuvalent	MT
10:00am	GSK completes USD10.6 billion acquisition of Nuvalent	AN
09:30am	GSK Closes $10.6 Billion Purchase of Nuvalent	MT
08:27pm	Nuvalent, Inc.(NasdaqGS:NUVL) dropped from S&P Biotechnology Select Industry Index	CI
08:27pm	Nuvalent, Inc.(NasdaqGS:NUVL) dropped from S&P Global BMI Index	CI
08:27pm	Nuvalent, Inc.(NasdaqGS:NUVL) dropped from S&P TMI Index	CI
Jul. 10	GSK, Hansoh's targeted cancer drug hits main survival goal in China trial	RE
Jul. 06	Novartis to Buy Myricx Bio for Up to $1.5 Billion -- Update	DJ
Jun. 28	Nuvalent, Inc.(NasdaqGS:NUVL) added to Russell 2000 Growth-Defensive Index	CI
Jun. 28	Nuvalent, Inc.(NasdaqGS:NUVL) added to Russell 2000 Defensive Index	CI
Jun. 25	Major deals involving US drugmakers and biotechs over the past decade	RE
Jun. 24	GSK Unit Launches Tender Offer for Nuvalent Acquisition	MT
Jun. 24	GSK Kicks Off Tender Offer to Buy Cancer Therapies Company Nuvalent	MT
Jun. 24	GSK launches tender offer for USD10.6 billion purchase of Nuvalent	AN